Allergan Plc (AGN)

146.34
NYSE : Health Technology
Prev Close 149.30
Day Low/High 145.84 / 149.61
52 Wk Low/High 125.84 / 197.00
Avg Volume 2.89M
Exchange NYSE
Shares Outstanding 332.61M
Market Cap 49.66B
EPS -15.30
P/E Ratio N/A
Div & Yield 2.96 (1.89%)

A Pharma Giant, an Airline and Other Stocks That Look Good Short

AGN, AVA, ALK, RLI and CRT all recently were downgraded by TheStreet's Quant Ratings.

How Are My Ideas Working Out? January Trade Review (Part 2)

How Are My Ideas Working Out? January Trade Review (Part 2)

Clearly, the first half of the month shaped up better than the second half.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ALEX, CATS, EXTR, LAD Downgrades: AGN Initiations: LBC, MRBK, SBT Read on to get TheStreet Quant Ratings' detailed report:

What Boeing's Report Means for U.S. Companies With China Exposure

What Boeing's Report Means for U.S. Companies With China Exposure

Kate Warne, investment strategist at Edward Jones, talked to TheStreet about what Boeing's report means for U.S. companies with exposure to China, Apple's beat and how the healthcare sector is looking.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Allergan Plc. Of Class Action Lawsuit And Upcoming Deadline - AGN

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Allergan Plc. Of Class Action Lawsuit And Upcoming Deadline - AGN

NEW YORK, Jan. 29, 2019 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Allergan plc.

Allergan Tumbles After Swinging to Fourth-Quarter Loss

Allergan Tumbles After Swinging to Fourth-Quarter Loss

Botox maker reports a fourth-quarter loss of $4.3 billion, a reversal from a year-earlier profit of $3.05 billion.

Sloppy Earnings, China's Economy, AMD Earnings Preview: Market Recon

Sloppy Earnings, China's Economy, AMD Earnings Preview: Market Recon

What we have seen of late from a number of chip producers really might be interpreted as pre-recessionary.

Allergan Reports Fourth Quarter And Full-Year 2018 Financial Results

Allergan Reports Fourth Quarter And Full-Year 2018 Financial Results

- Full-Year 2018 GAAP Net Revenues of $15.8 Billion; Q4 2018 GAAP Net Revenues of $4.1 Billion -

New BOTOX® Cosmetic (onabotulinumtoxinA) "Own Your Look" Campaign Brings Fresh Face To Trusted Brand

New BOTOX® Cosmetic (onabotulinumtoxinA) "Own Your Look" Campaign Brings Fresh Face To Trusted Brand

Campaign targets new generation of users with an updated, modern approach

Earnings Preview: Apple, AMD, Verizon, Other Giants to Report Crucial Q4

Earnings Preview: Apple, AMD, Verizon, Other Giants to Report Crucial Q4

Eight important companies report earnings between Monday and Tuesday. Don't miss them.

Allergan Could Retest Its December Low Before a Better Rally Attempt

Allergan Could Retest Its December Low Before a Better Rally Attempt

Allergan could move higher but some sort of retest of the December low seems in order in the short to intermediate term.

The Earnings Super Bowl: Cramer's 'Mad Money' Recap (Friday 1/25/19)

The Earnings Super Bowl: Cramer's 'Mad Money' Recap (Friday 1/25/19)

Jim Cramer's plan for getting through the heart of earnings season next week.

ALLERGAN SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Allergan Plc. - AGN

ALLERGAN SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Allergan Plc. - AGN

NEW ORLEANS, Jan. 25, 2019 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 19, 2019 to file lead plaintiff applications in a securities class action lawsuit against Allergan plc.

Allergan Announces Increased Quarterly Dividend And Annual General Meeting Of Shareholders Date

Allergan Announces Increased Quarterly Dividend And Annual General Meeting Of Shareholders Date

- First Quarter 2019 Cash Dividend of $0.74 Per Ordinary Share to be Paid on March 15, 2019; Record Date of February 15, 2019 -

Amgen And Allergan Announce Positive Top-Line Results From Phase 1/ Phase 3 Study Of ABP 798, Biosimilar Candidate To Rituximab

Amgen And Allergan Announce Positive Top-Line Results From Phase 1/ Phase 3 Study Of ABP 798, Biosimilar Candidate To Rituximab

Study Evaluated Pharmacokinetics, Efficacy and Safety of ABP 798 Compared to Rituximab in Patients With Moderate-to-Severe Rheumatoid Arthritis

Jim Cramer: What Are We to Make of Today's Market Decline?

Jim Cramer: What Are We to Make of Today's Market Decline?

Is it a retest based on the damage the Fed has already done, the result of a breakdown in trade talks or a sign of a slowing global economy?

Power of Positives: Cramer's 'Mad Money' Recap (Thursday 1/17/19)

Power of Positives: Cramer's 'Mad Money' Recap (Thursday 1/17/19)

Jim Cramer talks about how this market is taking its cues from the positives, and shrugging off the negatives.

Jim Cramer: This Market Takes Its Cue From the Positive and Ignores the Negative

Jim Cramer: This Market Takes Its Cue From the Positive and Ignores the Negative

So far 2019 is proving to be a year where things have a habit of working out right.

Try This Allergan Two-Week Setup

Try This Allergan Two-Week Setup

The company is set to report earnings on Jan. 29, so traders have a couple of weeks to watch the action.

Tumultuous, but Positive: Cramer's 'Mad Money' Recap (Friday 1/11/19)

Tumultuous, but Positive: Cramer's 'Mad Money' Recap (Friday 1/11/19)

This will be the craziest reporting season we've seen in ages, says Jim Cramer. He's got your game plan for next week.

Allergan Must Prove Itself With Signs of More Aggressive Buying

Allergan Must Prove Itself With Signs of More Aggressive Buying

A three-year decline in the shares of the maker of Botox will take more than a two-week bounce to reverse.

FAANG Is Back: Cramer's 'Mad Money' Recap (Tuesday 1/8/19)

FAANG Is Back: Cramer's 'Mad Money' Recap (Tuesday 1/8/19)

Plus: Jim Cramer interviews Apple CEO Tim Cook about innovation, investments and healthcare technology.

Real Money Post Industrial Average Outperformed the Market in 2018

Real Money Post Industrial Average Outperformed the Market in 2018

The RMPIA index was up for the year, while the S&P 500, DJIA, Russell 2000 and Nasdaq all finished 2018 in the red.

Allergan To Establish R&D Presence In Cambridge, Massachusetts

Allergan To Establish R&D Presence In Cambridge, Massachusetts

- The facility, located in Kendall Square, is expected to open in 1Q2019 -

ALLERGAN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Allergan Plc. - AGN

ALLERGAN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Allergan Plc. - AGN

NEW ORLEANS, Jan. 4, 2019 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C.

Allergan To Report Fourth Quarter And Full Year 2018 Earnings And Host Conference Call And Webcast

Allergan To Report Fourth Quarter And Full Year 2018 Earnings And Host Conference Call And Webcast

DUBLIN, Jan. 3, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced it intends to release fourth quarter and full year 2018 financial results on Tuesday, January 29, 2019, prior to the open of U.

Allergan To Present At The 37th Annual J.P. Morgan Healthcare Conference

Allergan To Present At The 37th Annual J.P. Morgan Healthcare Conference

DUBLIN, Dec. 24, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Chairman and CEO Brent Saunders will present at the 37 th Annual J.

TheStreet Quant Rating: D+ (Sell)